Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Femasys Inc. - Common Stock
(NQ:
FEMY
)
2.960
+0.230 (+8.42%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Femasys Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Femasys Advances Global Growth with Second Partner Order for FemBloc® in Europe
November 10, 2025
From
Femasys Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
November 10, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
November 07, 2025
Via
Benzinga
Femasys Stock Sparks Retail Frenzy After FDA Clears Final Phase Of FemBloc Trial And $58M Financing
↗
November 04, 2025
Femasys secured FDA approval to proceed with the final phase of its pivotal FemBloc trial, a key step toward U.S. market approval for its non-surgical permanent birth control device.
Via
Stocktwits
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million
November 03, 2025
From
Femasys Inc.
Via
GlobeNewswire
Get insights into the top gainers and losers of Friday's pre-market session.
↗
October 24, 2025
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
Femasys Announces Initiation of Post-Market Surveillance Study for FemBloc® Permanent Birth Control in Europe
October 22, 2025
From
Femasys Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 17, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
October 16, 2025
Via
Benzinga
Curious about the stocks that are showing activity after the closing bell on Thursday?
↗
October 16, 2025
The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today.
Via
Chartmill
Which stocks are experiencing notable movement on Thursday?
↗
October 16, 2025
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 16, 2025
Via
Benzinga
Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo
October 16, 2025
Will Showcase Latest Fertility Solutions
From
Femasys Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 14, 2025
Via
Benzinga
Keep an eye on the top gainers and losers in Wednesday's session.
↗
October 08, 2025
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
Unusual volume stocks are being observed in Wednesday's session.
↗
October 08, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets.
Via
Chartmill
Unusual volume stocks are being observed in Tuesday's session.
↗
October 07, 2025
On Tuesday, there are stocks with unusual volume. Let's take a look.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 07, 2025
Via
Benzinga
Roadzen Inc. (NASDAQ: RDZN) Completes $7M India Financing at 100% Premium – Paves Path to Higher Valuation | More Stocks Inside
October 06, 2025
Via
AB Newswire
Topics
Artificial Intelligence
These stocks are moving in today's session
↗
October 06, 2025
Here are the top movers in Monday's session, showcasing the stocks with significant price changes.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
October 06, 2025
Via
Benzinga
Monday's session: gap up and gap down stocks
↗
October 06, 2025
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via
Chartmill
Why AMD Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket
↗
October 06, 2025
Via
Benzinga
Wondering what's happening in today's pre-market session?
↗
October 06, 2025
Discover the top movers in Monday's pre-market session and stay informed about market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
October 06, 2025
Via
Benzinga
Curious about the stocks that are showing activity after the closing bell on Friday?
↗
October 03, 2025
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 03, 2025
Via
Benzinga
Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership
September 25, 2025
-- Femasys leverages Kebomed’s pan-European distribution strength to drive adoption of FemBloc permanent birth control in France and Benelux, unlocking significant market access --
From
Femasys Inc.
Via
GlobeNewswire
Femasys Partners with Medical Electronic Systems to Launch FemSperm™ Analysis Kit for use with FemaSeed
September 22, 2025
Addition strengthens FemSperm family of products and enables gynecologists to offer complete in-office sperm handling for FemaSeed Intratubal Insemination
From
Femasys Inc.
Via
GlobeNewswire
Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed®
September 11, 2025
-- Following the Setup Kit, the Insemination Kit completes the sperm preparation portion of FemSperm enabling gynecology call point activation to drive revenue growth --
From
Femasys Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
